潜在的A型链杆菌疫苗的潜在全球性成本效益以及相关的实施努力
Jung-Seok Lee1, Vittal Mogasale2, Sol Kim2
1International Vaccine Institute, Seoul, South Korea. jungseoklee@gmail.com.
NPJ vaccines
|August 25, 2023
概括
一种假设的A组链球菌 (链球菌A) 疫苗可以在全球范围内具有成本效益. 这种疫苗有潜力显著降低所有收入层面的链杆菌A相关疾病的负担.
科学领域:
- 全球健康 全球健康
- 疫苗学 疫苗学 疫苗学
- 卫生经济学 卫生经济学
背景情况:
- 甲型链球菌 (A型链球菌) 引起各种疾病,从喉炎到诸如风湿性心脏病 (RHD) 等严重疾病.
- 链杆菌A的全球影响需要探索有效的预防策略,包括疫苗接种.
研究的目的:
- 为了估计一个假设的链杆菌A疫苗的全球成本效益.
- 确定与世卫组织首选产品特征一致的最大可接受的疫苗接种成本.
主要方法:
- 综合流行病学影响预测的成本效益分析.
- 根据人均GDP和健康机会成本估计疫苗接种成本门.
- 在出生和5岁时建模例行疫苗接种.
主要成果:
- 最大成本效益的疫苗接种价格因收入水平而异,低收入国家为37美元至69美元,高收入国家为385美元至489美元.
- 门成本是敏感的疫苗的疗效和免疫的持续时间.
- 一种具有成本效益的链杆菌A疫苗预计将在所有收入环境中减少发病率和死亡率.
结论:
- 在全球范围内,A型链球菌A疫苗是一个具有成本效益的公共卫生干预措施.
- 疫苗接种策略可以显著减轻与A型链球菌感染相关的疾病负担.
- 进一步的研究应该考虑疫苗的有效性和免疫力减弱,以准确地估计成本效益.
更多相关视频
08:47Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
Published on: April 5, 2019
12.3K
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
15.1K
相关概念视频
01:22Healthcare Associated Infections II: Preventive Measures
2.7K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.7K
01:51Vaccinations
44.7K
Overview
44.7K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
147
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
147
01:28Antimicrobial Effectiveness
48
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
48
01:21Rheumatic Heart Disease III: Medical Management
13
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
13
01:26Tonsillitis II: Management
134
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
134